Rwanda Food and Drugs Authority (FDA) has temporarily banned the sale and use of Unibrol (Aminosidine Sulphate) USP 250 mg tablets, citing quality concerns.
Manufactured by Universal Corporation Ltd, Kenya-the medicine is a type of antibiotic that has been administered by mouth in the treatment of intestinal infection, including amoebiasis among humans.
The latest temporary ban follows the November 29, 2020, move by FDA where it recalled two batches of the drug in question with No 5806898 and…
Read more on AllAfrica.com
Main News – Central Africa